1. Home
  2. ONEW vs VTVT Comparison

ONEW vs VTVT Comparison

Compare ONEW & VTVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OneWater Marine Inc.

ONEW

OneWater Marine Inc.

HOLD

Current Price

$8.95

Market Cap

155.3M

ML Signal

HOLD

Logo vTv Therapeutics Inc.

VTVT

vTv Therapeutics Inc.

HOLD

Current Price

$36.70

Market Cap

143.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ONEW
VTVT
Founded
2014
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Auto & Home Supply Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
155.3M
143.7M
IPO Year
2019
2015

Fundamental Metrics

Financial Performance
Metric
ONEW
VTVT
Price
$8.95
$36.70
Analyst Decision
Buy
Strong Buy
Analyst Count
4
5
Target Price
$16.75
$53.00
AVG Volume (30 Days)
151.3K
51.5K
Earning Date
04-30-2026
03-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
2.77
N/A
Revenue
$1,872,334,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$3.27
N/A
P/E Ratio
$3.19
N/A
Revenue Growth
5.62
N/A
52 Week Low
$8.12
$14.00
52 Week High
$17.92
$44.00

Technical Indicators

Market Signals
Indicator
ONEW
VTVT
Relative Strength Index (RSI) 38.02 52.94
Support Level $8.12 $31.37
Resistance Level $9.83 $41.88
Average True Range (ATR) 0.65 3.67
MACD 0.11 0.21
Stochastic Oscillator 36.73 71.50

Price Performance

Historical Comparison
ONEW
VTVT

About ONEW OneWater Marine Inc.

OneWater Marine Inc is a recreational marine retailer in the United States. The company operates in two segments: Dealership and Distribution. The Dealership segment is involved in selling new and pre-owned boats. It also arranges financing and insurance products, provides repairs and maintenance services, offers marine-related parts and accessories, and supplies slip and storage accommodations at certain locations. The Distribution segment focuses on the manufacturing, assembly, and distribution of marine-related products. These products are supplied to distributors, box retailers, and online retailers through a network of warehouses and distribution centers. The company generates the majority of its revenue from the Dealership segment.

About VTVT vTv Therapeutics Inc.

vTv Therapeutics Inc is a late-stage biopharmaceutical company focused on developing oral, small molecule drug candidates intended to help treat people living with diabetes and other chronic diseases. Its clinical pipeline is led by cadisegliatin, currently in a Phase 3 trial, a potential novel first-in-class oral liver-selective glucokinase activator being investigated for the treatment of type 1 diabetes. The group and its development partners are investigating multiple molecules across different indications for chronic diseases. Its product pipeline are HPP737, Azeliragon, TTP-RA, TTP273, HPP971 / HPP3033, and HPP593.

Share on Social Networks: